Search - tctmd.com

Displaying 181 - 200 of 719

Sort: Relevancy | Date

Presentation TCT 2022

CONFIDENCE Registry: Valve Hemodynamics and 1-Year Survival Following Implantation of the PorticoTM Valve in Experienced TAVI Centers

Presenter: Helge Möllmann

September 18, 2022

News Conference News TCT 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Shelley Wood

September 18, 2022

Presentation TCT 2022

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Presenter: ShaoLiang Chen

September 18, 2022

Presentation TCT 2022

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Presenter: Deepak Bhatt

September 18, 2022

Presentation TCT 2022

A Clinical Cardiologist’s View on How to Choose Revascularization Strategies

Presenter: Patrick O'Gara

September 18, 2022

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Todd Neale

September 18, 2022

Presentation TCT 2022

Case 2: COVID Patient With Clot in Transit

Presenter: Matthew Finn

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Presentation TCT 2022

Keynote Lecture: My Experience With Perforations Over the Lifetime in Interventional Cardiology

Presenter: Antonio Colombo

September 17, 2022

News Conference News TCT 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Yael L. Maxwell

September 17, 2022

News Conference News TCT 2022

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

Todd Neale

September 17, 2022

Presentation TCT 2022

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Presenter: Felix Mahfoud

September 17, 2022

Presentation TCT 2022

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Presenter: Naomi Fisher

September 17, 2022

Presentation TCT 2022

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Presenter: David Kandzari

September 17, 2022

Presentation TCT 2022

Novel Approaches to Assess Hypertension Control Outside the Office

Presenter: Naomi Fisher

September 17, 2022

Presentation TCT 2022

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

Presenter: Melvin Lobo

September 17, 2022

Presentation TCT 2022

Lifetime Management, Durability and Clinical Relevance to Patients

Presenter: John Webb

September 17, 2022

Presentation TCT 2022

Dietary and Lifestyle Approaches to Hypertension Management: What’s New and What’s Changed

Presenter: Debbie Cohen

September 17, 2022

Presentation TCT 2022

Have We Gotten to the Final Word on Paclitaxel Safety?

Presenter: Eric Secemsky

September 17, 2022

Presentation TCT 2022

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Presenter: Marc Bonaca

September 17, 2022

Advertisement

CONFIDENCE Registry: Valve Hemodynamics and 1-Year Survival Following Implantation of the PorticoTM Valve in Experienced TAVI Centers

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

A Clinical Cardiologist’s View on How to Choose Revascularization Strategies

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Case 2: COVID Patient With Clot in Transit

FLASH: More Data to Support Mechanical Thrombectomy in PE

Keynote Lecture: My Experience With Perforations Over the Lifetime in Interventional Cardiology

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Novel Approaches to Assess Hypertension Control Outside the Office

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

Lifetime Management, Durability and Clinical Relevance to Patients

Dietary and Lifestyle Approaches to Hypertension Management: What’s New and What’s Changed

Have We Gotten to the Final Word on Paclitaxel Safety?

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content